ArticleAnalytical cellular pathology (Amsterdam)2021

Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9.

Xinxin Kou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.